| Literature DB >> 32820593 |
Kaoru Fujinami1,2,3,4, Akio Oishi5, Lizhu Yang1,2, Gavin Arno1,3,4,6, Nikolas Pontikos1,3,4, Kazutoshi Yoshitake7, Yu Fujinami-Yokokawa1,3,8,9, Xiao Liu1,2,10, Takaaki Hayashi11, Satoshi Katagiri11, Kei Mizobuchi11, Atsushi Mizota12, Kei Shinoda12,13, Natsuko Nakamura1,12,14, Toshihide Kurihara2, Kazuo Tsubota2, Yozo Miyake1,15,16, Takeshi Iwata7, Akitaka Tsujikawa5, Kazushige Tsunoda1.
Abstract
Variants in the PROM1 gene are associated with cone (-rod) dystrophy, macular dystrophy, and other phenotypes. We describe the clinical and genetic characteristics of 10 patients from eight Japanese families with PROM1-associated retinal disorder (PROM1-RD) in a nationwide cohort. A literature review of PROM1-RD in the Japanese population was also performed. The median age at onset/examination of 10 patients was 31.0 (range, 10-45)/44.5 (22-73) years. All 10 patients showed atrophic macular changes. Seven patients (70.0%) had spared fovea to various degrees, approximately half of whom had maintained visual acuity. Generalized cone (-rod) dysfunction was demonstrated in all nine subjects with available electrophysiological data. Three PROM1 variants were identified in this study: one recurrent disease-causing variant (p.Arg373Cys), one novel putative disease-causing variant (p.Cys112Arg), and one novel variant of uncertain significance (VUS; p.Gly53Asp). Characteristic features of macular atrophy with generalized cone-dominated retinal dysfunction were shared among all 10 subjects with PROM1-RD, and the presence of foveal sparing was crucial in maintaining visual acuity. Together with the three previously reported variants [p.R373C, c.1551+1G>A (pathogenic), p.Asn580His (likely benign)] in the literature of Japanese patients, one prevalent missense variant (p.Arg373Cys, 6/9 families, 66.7%) detected in multiple studies was determined in the Japanese population, which was also frequently detected in the European population.Entities:
Keywords: PROM1; autosomal dominant; cone dystrophy; cone rod dystrophy; macular dystrophy
Mesh:
Substances:
Year: 2020 PMID: 32820593 DOI: 10.1002/ajmg.c.31826
Source DB: PubMed Journal: Am J Med Genet C Semin Med Genet ISSN: 1552-4868 Impact factor: 3.908